12/19
04:08 pm
acad
Acadia Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 [Yahoo! Finance]
Low
Report
Acadia Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 [Yahoo! Finance]
12/19
04:05 pm
acad
Acadia Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025
Low
Report
Acadia Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025
12/16
04:05 pm
acad
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/11
04:19 pm
acad
Acadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million [Yahoo! Finance]
Medium
Report
Acadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million [Yahoo! Finance]
12/11
04:05 pm
acad
Acadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million
Medium
Report
Acadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million
12/9
09:11 am
acad
Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer [Yahoo! Finance]
Medium
Report
Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer [Yahoo! Finance]
12/9
09:00 am
acad
Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer
Medium
Report
Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer
12/3
11:04 am
acad
Why Acadia Pharmaceuticals (ACAD) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
Low
Report
Why Acadia Pharmaceuticals (ACAD) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
12/3
10:01 am
acad
Implied Volatility Surging for ACADIA Pharmaceuticals (ACAD) Stock Options [Yahoo! Finance]
Low
Report
Implied Volatility Surging for ACADIA Pharmaceuticals (ACAD) Stock Options [Yahoo! Finance]
11/27
11:17 am
acad
ACAD Signs License Deal With Saniona for Rights to Neurology Drug [Yahoo! Finance]
Low
Report
ACAD Signs License Deal With Saniona for Rights to Neurology Drug [Yahoo! Finance]
11/26
04:14 pm
acad
Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711 [Yahoo! Finance]
Low
Report
Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711 [Yahoo! Finance]
11/26
04:05 pm
acad
Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711
Low
Report
Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711
11/21
04:05 pm
acad
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Low
Report
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
11/15
04:05 pm
acad
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/15
12:02 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
11/12
11:56 am
acad
Here's Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock [Yahoo! Finance]
Low
Report
Here's Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock [Yahoo! Finance]
11/11
10:53 am
acad
Acadia Pharmaceuticals: Proving The Naysayers Wrong [Seeking Alpha]
Low
Report
Acadia Pharmaceuticals: Proving The Naysayers Wrong [Seeking Alpha]
11/9
08:10 am
acad
ACADIA Pharmaceuticals Inc. Just Recorded A 43% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
Low
Report
ACADIA Pharmaceuticals Inc. Just Recorded A 43% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
11/7
11:47 am
acad
Acadia's Q3 Earnings Beat, Nuplazid & Daybue Drive Revenue Growth [Yahoo! Finance]
Low
Report
Acadia's Q3 Earnings Beat, Nuplazid & Daybue Drive Revenue Growth [Yahoo! Finance]
11/7
08:36 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
11/7
08:36 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
11/7
06:17 am
acad
ACADIA Pharmaceuticals Inc (ACAD) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... [Yahoo! Finance]
Medium
Report
ACADIA Pharmaceuticals Inc (ACAD) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... [Yahoo! Finance]
11/6
05:28 pm
acad
Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview [Yahoo! Finance]
Medium
Report
Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview [Yahoo! Finance]
11/6
04:13 pm
acad
Acadia Pharma GAAP EPS of $0.20 beats by $0.06, revenue of $250.4M beats by $1.56M Nov. 06, 2024 4:09 PM ET By: Urvi Shah , SA News Editor [Seeking Alpha]
Medium
Report
Acadia Pharma GAAP EPS of $0.20 beats by $0.06, revenue of $250.4M beats by $1.56M Nov. 06, 2024 4:09 PM ET By: Urvi Shah , SA News Editor [Seeking Alpha]
11/6
04:05 pm
acad
Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview
Medium
Report
Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview